Blood pressure monitoring
-
Blood pressure monitoring · Aug 2017
Multicenter Study Comparative StudyClinical validation of a new wrist continuous noninvasive hemodynamic monitoring system in comparison with invasive radial artery measurement.
An ideal arterial pressure monitoring system for perioperative care is required to be accurate, noninvasive, continuous, and risk free. Although several continuous noninvasive arterial pressures (CNAP) are determined on the finger, a new wrist CNAP monitoring system was developed. This prospective study was designed as a randomized-controlled trial to assess its validity in comparison with invasive arterial pressure (IAP) monitoring. ⋯ The new wrist CNAP monitoring system showed an acceptable agreement and interchangeability with the IAP.
-
Blood pressure monitoring · Dec 2009
Multicenter StudyEvaluation, management, and referral of elderly emergency department patients with elevated blood pressure.
To determine blood pressure (BP) reassessment rates and to describe the evaluation and outpatient referral rates of elderly emergency department (ED) patients with elevated BP. ⋯ Unlike other ED-based studies of adult hypertensive patients, BP reassessment in the elderly occurred in the majority. Referral and intervention rates, however, were low.
-
Blood pressure monitoring · Jun 2009
Randomized Controlled Trial Multicenter Study Comparative StudyEffects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Previous studies using the combination of angiotensin-receptor blockers and hydrochlorothiazide (HCTZ) have shown superior ambulatory blood pressure (ABP) reduction in study participants with stage 2 hypertension compared with monotherapy. ⋯ On the basis of ABP monitoring but not office measurements, the fixed-dose combination of valsartan/HCTZ is a significantly more effective treatment regimen than amlodipine/HCTZ, with similar tolerability.
-
Blood pressure monitoring · Apr 2005
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
There is a lack of data on the effects of angiotensin-receptor blocker and diuretic combinations on ambulatory blood pressure (ABP) in hypertensive patients with additional cardiovascular risk factors. ⋯ The fixed-dose combination of valsartan 160 mg+HCTZ 25 mg od is an attractive therapeutic option measured on the effects on 24-h ABPM, night-time and daytime BP reduction and control rates in hypertensive patients at additional cardiovascular risk.
-
Blood pressure monitoring · Apr 2002
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialAn ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan.
The primary objective of this study was to compare the change from baseline in mean diastolic ambulatory blood pressure (ABP) at 24 h post dose (trough measurement) after 8 weeks of treatment with irbesartan or valsartan in subjects with mild-to-moderate hypertension. Secondary objectives included comparing the mean changes from baseline in systolic ABP at trough; 24-h ABP; morning and night-time ABP; self-measured systolic blood pressure (SBP) and diastolic blood pressure (DBP); and office-measured SBP and DBP at trough. ⋯ Irbesartan was more effective than valsartan in reducing DBP and SBP at trough and in providing greater overall 24-h blood pressure-lowering efficacy.